Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

JAN 08, 2015 - Yahoo! News

A Must Read - Share

FDA panel unanimously backs Novartis' copy of Amgen's Neupogen

By Natalie Grover and Samantha Kareen Nair (Reuters) - A panel to the U.S. Food and Drug Administration unanimously backed the approval of Novartis AG's copy of Amgen Inc's blockbuster cancer drug Neupogen, setting the stage for the regulator's first approval of a biosimilar. The United States has lagged other markets in establishing a regulatory framework for biosimilars, copies of ...

Tags: FDA panel unanimously backs Novartis' copy of Amgen's Neupogen,  Amgen Latest News

JAN 06, 2015 - Philadelphia Inquirer

A Must Read - Share

First biosimilar gets FDA staff nod as Amgen drug draws imitator

The first attempt in the United States to bring to market cheaper imitations of expensive biologic drugs gained support from U.S. regulators.

Tags: First biosimilar gets FDA staff nod as Amgen drug draws imitator,  Amgen Latest News

JAN 05, 2015 - Yahoo! News

A Must Read - Share

Amgen, Kite Pharma ink deal to develop cancer immunotherapies

(Reuters) - Amgen Inc and Kite Pharma Inc said they entered into a deal to develop and market cancer immunotherapies using Amgen's cancer targets and Kite's technology platform. Amgen will pay Kite Pharma $60 million upfront and fund research costs through the filing of a new drug application. After that each company will conduct and fund trials for their therapeutic ...

Tags: Amgen, Kite Pharma ink deal to develop cancer immunotherapies,  Amgen Latest News

JAN 05, 2015 - Yahoo! News

A Must Read - Share

FDA staff recommends Novartis copy of Amgen's Neupogen

(Reuters) - Staff reviewers at the U.S. Food and Drug Administration recommended approval for Novartis AG's copy of Amgen Inc's blockbuster cancer drug Neupogen. Novartis's drug is the first to be reviewed in the United States under the so-called biosimilar pathway. The reviewers found no "clinically meaningful differences" between the two drugs, the FDA said. (http://1.usa.gov/1DoT7eb) The injectable biotech medicine ...

Tags: FDA staff recommends Novartis copy of Amgen's Neupogen,  Amgen Latest News